NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
PDS Biotechnology Corporation (NASDAQ: PDSB)
PDSB Technical Analysis
1.5
As on 9th Jun 2023 PDSB STOCK Price closed @ 5.90 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.26 & Sell for SHORT-TERM with Stoploss of 6.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PDSBSTOCK Price
Open | 5.82 | Change | Price | % |
High | 5.96 | 1 Day | 0.08 | 1.37 |
Low | 5.51 | 1 Week | -3.68 | -38.41 |
Close | 5.90 | 1 Month | -0.18 | -2.96 |
Volume | 1039300 | 1 Year | -3.08 | -34.30 |
52 Week High 13.20 | 52 Week Low 2.97 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
PDSB Daily Charts |
PDSB Intraday Charts |
Whats New @ Bazaartrend |
PDSB Free Analysis |
|
PDSB Important Levels Intraday
RESISTANCE | 6.77 |
RESISTANCE | 6.49 |
RESISTANCE | 6.32 |
RESISTANCE | 6.15 |
SUPPORT | 5.65 |
SUPPORT | 5.48 |
SUPPORT | 5.31 |
SUPPORT | 5.03 |
PDSB Forecast May 2024
4th UP Forecast | 11.58 |
3rd UP Forecast | 9.76 |
2nd UP Forecast | 8.63 |
1st UP Forecast | 7.51 |
1st DOWN Forecast | 4.29 |
2nd DOWN Forecast | 3.17 |
3rd DOWN Forecast | 2.04 |
4th DOWN Forecast | 0.22 |
PDSB Weekly Forecast
4th UP Forecast | 8.66 |
3rd UP Forecast | 7.77 |
2nd UP Forecast | 7.23 |
1st UP Forecast | 6.68 |
1st DOWN Forecast | 5.12 |
2nd DOWN Forecast | 4.57 |
3rd DOWN Forecast | 4.03 |
4th DOWN Forecast | 3.14 |
PDSB Forecast2024
4th UP Forecast | 26.63 |
3rd UP Forecast | 19.98 |
2nd UP Forecast | 15.87 |
1st UP Forecast | 11.76 |
1st DOWN Forecast | 0.04 |
2nd DOWN Forecast | -4.07 |
3rd DOWN Forecast | -8.18 |
4th DOWN Forecast | -14.83 |
PDS Biotechnology Corporation ( NASDAQ USA Symbol : PDSB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PDSB Other Details
Segment | EQ | |
Market Capital | 343359488.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
PDSB Address
PDSB Latest News
PDSB Business Profile
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Address: 25B Vreeland Road, Florham Park, NJ, United States, 07932
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service